Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
Authors:
- Irene Pachón-AngonaIPIrene Pachón-Angona
- Paul J. BernardPBPaul J. Bernard
- Alexey SimakovASAlexey Simakov
- Maciej MajMMMaciej Maj
- Krzysztof JozwiakKrzysztof Jozwiak
- Anna NovotnaANAnna Novotna
- Carina LemkeCLCarina Lemke
- Michael GütschowMichael Gütschow
- Helene MartinHMHelene Martin
- María-Jesús Oset-GasqueMaría-Jesús Oset-Gasque
- José-Marco ContellesJosé-Marco Contelles
- Lhassane IsmailiLILhassane Ismaili
Open Access
- 17 January 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 121
Abstract
This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.Keywords
Funding Information
- Regional Council of Franche-Comté (2022Y-13659, 13660 ACCURATE PROJECT)
This publication has 45 references indexed in Scilit:
- Inhibition of Cathepsin S Produces Neuroprotective Effects after Traumatic Brain Injury in MiceMediators of Inflammation, 2013
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson diseaseFree Radical Biology and Medicine, 2013
- Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer DiseaseJournal of Neuroscience, 2012
- Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: The case for isradipineBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- The effect of l-deprenyl on tissue mRNA expressions of NOS isoforms and NO levels in an experimental diabetes mellitus modelJournal of Neural Transmission, 2007
- Modulation of brain mitochondrial function by deprenylNeurochemistry International, 2006
- Novel cytoprotective mechanism of anti-parkinsonian drug deprenyl: PI3K and Nrf2-derived induction of antioxidative proteinsBiochemical and Biophysical Research Communications, 2006
- Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's diseaseAnnals of Neurology, 1997
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982